QSC PHARMA GRADE
🇮🇳 India Warehouse112-Count Pack
What is Lyvelsa 20mg (1X14) (SACUBITRIL / VALSARTAN)?
ARNI for heart failure with reduced ejection fraction (HFrEF) — the most significant advance in heart failure pharmacology in decades. Now standard of care in HFrEF.
How it Works
Sacubitril inhibits neprilysin preventing natriuretic peptide degradation. Valsartan blocks AT1 receptor. Together they augment natriuretic peptides and block angiotensin II — superior to ACEI or ARB alone.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | SACUBITRIL / VALSARTAN |
| Dose per Tablet | 20MG |
| Pack Size | 112 tablets |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Hypotension (especially first dose), hyperkalemia, renal impairment, angioedema.
Safety Warnings
⚠️ NEVER use within 36 hours of ACE inhibitor — potentially fatal angioedema. Contraindicated in pregnancy. Monitor blood pressure, potassium, renal function closely at initiation.

